InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 04/06/2021 1:14:09 PM

Tuesday, April 06, 2021 1:14:09 PM

Post# of 14953
HERE ARE MY TOP 10 Sorrento SURPRISES OVER THE PAST 12 MONTHS.
1. ACEA acquisition
2. SmartPharm acquisition
3. ADNAB(MAYO clinic program) acquisition
4. 2020 Covid Mab triple program
5. DARPA $34 Million Covid grant
6. RTX pain program
7. DAR-T program program potential(10-100 times CAR-T potency)
8. COVI-MSC result against ARDS.
9. ABIVIRTINIB potential in cancer and Covid
10. STRONG FUNDING! Sorrento has invested wisely and has 8.2 million shares of ImmunityBio, 20 million shares of Celularity and 35% of ImmuneOncia. These are worth many hundreds of millions and the PSS lawsuit will soon be settled with very large potential gains. And it has many attractive programs to partner for upfront, milestone and royalty payments! Huge portfolio AND huge assets!

"The refusal of the real is the number one dogma of our time" Rene Girard